These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17425972)
1. [Preparation of cisplatin-impregnated coral hydroxyapatite drug delivery system]. Yang JC; Yin QS; Lin J; Huang HY; Ding HW; Zhang Y; Li J Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):283-5. PubMed ID: 17425972 [TBL] [Abstract][Full Text] [Related]
2. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874 [TBL] [Abstract][Full Text] [Related]
3. Hydroxyapatite crystals as a local delivery system for cisplatin: adsorption and release of cisplatin in vitro. Barroug A; Glimcher MJ J Orthop Res; 2002 Mar; 20(2):274-80. PubMed ID: 11918306 [TBL] [Abstract][Full Text] [Related]
4. [Biocompatibility of adult human osteoblasts with coral-derived hydroxyapatite in vitro]. Ren GH; Pei GX; Gu LQ; Wang K; Jin D; Wei KH; Chen B; Mo XH Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):974-8. PubMed ID: 12433620 [TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin. Moreno D; Zalba S; Colom H; Trocóniz IF; Tros de Ilarduya C; Garrido MJ Eur J Pharm Sci; 2009 Jun; 37(3-4):341-50. PubMed ID: 19491025 [TBL] [Abstract][Full Text] [Related]
6. [Development of a slow release system of anti-cancer drugs retained in calcium-hydroxyapatite ceramic]. Uchida A; Shinto Y; Araki N; Ono K Gan To Kagaku Ryoho; 1989 Sep; 16(9):3231-5. PubMed ID: 2551252 [TBL] [Abstract][Full Text] [Related]
7. [Determination of silver content in silver-loaded coral hydroxyapatite in relation to the biocompatibility]. Zhang Y; Yin QS; Zhang Y; Li J; Chen XQ; Fu D Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1411-5. PubMed ID: 21868334 [TBL] [Abstract][Full Text] [Related]
8. [Preparation and biological activity of poly (gamma-glutamic acid) -cisplatin conjugate]. Jin L; Ye HF; Huang J; Jiang L; Hu RZ; Wu ZR Yao Xue Xue Bao; 2007 Jun; 42(6):611-7. PubMed ID: 17702397 [TBL] [Abstract][Full Text] [Related]
9. Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. Barroug A; Kuhn LT; Gerstenfeld LC; Glimcher MJ J Orthop Res; 2004 Jul; 22(4):703-8. PubMed ID: 15183424 [TBL] [Abstract][Full Text] [Related]
10. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro. Xie J; Tan RS; Wang CH J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769 [TBL] [Abstract][Full Text] [Related]
12. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Foroodi F; Duivenvoorden WC; Singh G Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028 [TBL] [Abstract][Full Text] [Related]
13. [Application of a slow release system of anti-cancer drug retained in calcium hydroxyapatite ceramic against experimental bone and soft tissue sarcoma]. Shinto Y; Uchida A; Araki N; Ono K Gan To Kagaku Ryoho; 1991 Feb; 18(2):221-6. PubMed ID: 1847029 [TBL] [Abstract][Full Text] [Related]
14. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile. Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461 [TBL] [Abstract][Full Text] [Related]
15. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs. Ripamonti U; Crooks J; Khoali L; Roden L Biomaterials; 2009 Mar; 30(7):1428-39. PubMed ID: 19081131 [TBL] [Abstract][Full Text] [Related]
16. Local delivery system of immune modulating drug for unresectable adenocarcinoma: in vitro experimental study and in vivo animal study. Lee DH; Kang SG; Jeong S; Yoon CJ; Choi JA; Byun JN; Park JH; Lee KB Cardiovasc Intervent Radiol; 2006; 29(5):832-7. PubMed ID: 16779692 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model. Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927 [TBL] [Abstract][Full Text] [Related]
18. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. Uchida A; Shinto Y; Araki N; Ono K J Orthop Res; 1992 May; 10(3):440-5. PubMed ID: 1314896 [TBL] [Abstract][Full Text] [Related]
19. [Effect of chemotherapy with cisplatin and rapamycin against Hep-2 cells in vitro]. Lei WB; Jia T; Su ZZ; Wen WP; Zhu XL Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1838-41. PubMed ID: 18971185 [TBL] [Abstract][Full Text] [Related]
20. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer]. Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]